According to Hoth Therapeutics's latest financial reports the company's current EPS (TTM) is -6,04ย โฌ. In 2022 the company made an earnings per share (EPS) of -9,33ย โฌ an increase over its 2021 EPS that were of -16,04ย โฌ.